1. Home
  2. PYPD vs VRME Comparison

PYPD vs VRME Comparison

Compare PYPD & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • VRME
  • Stock Information
  • Founded
  • PYPD 2008
  • VRME 1999
  • Country
  • PYPD Israel
  • VRME United States
  • Employees
  • PYPD N/A
  • VRME N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • VRME EDP Services
  • Sector
  • PYPD Health Care
  • VRME Technology
  • Exchange
  • PYPD Nasdaq
  • VRME Nasdaq
  • Market Cap
  • PYPD 16.3M
  • VRME 14.5M
  • IPO Year
  • PYPD 2020
  • VRME N/A
  • Fundamental
  • Price
  • PYPD $3.51
  • VRME $1.32
  • Analyst Decision
  • PYPD Buy
  • VRME Buy
  • Analyst Count
  • PYPD 2
  • VRME 1
  • Target Price
  • PYPD $12.00
  • VRME $1.50
  • AVG Volume (30 Days)
  • PYPD 5.2K
  • VRME 15.8K
  • Earning Date
  • PYPD 11-06-2024
  • VRME 11-06-2024
  • Dividend Yield
  • PYPD N/A
  • VRME N/A
  • EPS Growth
  • PYPD N/A
  • VRME N/A
  • EPS
  • PYPD N/A
  • VRME N/A
  • Revenue
  • PYPD N/A
  • VRME $25,428,000.00
  • Revenue This Year
  • PYPD N/A
  • VRME $1.14
  • Revenue Next Year
  • PYPD N/A
  • VRME $10.56
  • P/E Ratio
  • PYPD N/A
  • VRME N/A
  • Revenue Growth
  • PYPD N/A
  • VRME N/A
  • 52 Week Low
  • PYPD $2.95
  • VRME $0.85
  • 52 Week High
  • PYPD $9.20
  • VRME $2.45
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 50.62
  • VRME 48.69
  • Support Level
  • PYPD $3.31
  • VRME $1.28
  • Resistance Level
  • PYPD $3.62
  • VRME $1.43
  • Average True Range (ATR)
  • PYPD 0.17
  • VRME 0.11
  • MACD
  • PYPD 0.01
  • VRME -0.01
  • Stochastic Oscillator
  • PYPD 51.25
  • VRME 32.04

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: